| Market revenue in 2025 | USD 66.7 million |
| Market revenue in 2033 | USD 159.8 million |
| Growth rate | 11.7% (CAGR from 2026 to 2033) |
| Largest segment | Respiratory panels |
| Fastest growing segment | Gastrointestinal Panels |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Respiratory Panels, Gastrointestinal Panels, Sexually Transmitted Infection (STI) Panels, Bloodstream / Sepsis Panels, Central Nervous System (CNS) Panels, Tropical Disease Panels, Other Panels |
Publish Date: May 12, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Diasorin SpA | View profile | 3,233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | www.diasoringroup.com |
| Cepheid | View profile | 1001-5000 | Sunnyvale, California, United States, North America | www.cepheid.com |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| AusDiagnostics | View profile | 101-250 | Mascot, New South Wales, Australia, Oceania | www.ausdiagnostics.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Multiplex PCR Panel Testing Market Outlook will help companies and investors design strategic landscapes.
Respiratory Panels was the largest segment with a revenue share of 43.78% in 2025.
Horizon Databook has segmented the Japan multiplex pcr panel testing market based on respiratory panels, gastrointestinal panels, sexually transmitted infection (sti) panels, bloodstream / sepsis panels, central nervous system (cns) panels, tropical disease panels, other panels covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Multiplex PCR Panel Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Multiplex PCR Panel Testing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.